Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jul 2026 for Evolent Health, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Aammaad Shams: trading record in brief
This profile gathers the share dealings of Aammaad Shams in Evolent Health, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 1 March 2022 to 1 July 2026, the count stands at 10 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 6 July 2026: a share grant, in Evolent Health, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Aammaad Shams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
28,790 shares0Class A Common StockSEC:0001628908-26-000066:0
2,577 shares@ US$3.253.7% of flowClass A Common StockSEC:0001628908-26-000019:0
2,567 shares@ US$9.9812.2% of flowClass A Common StockSEC:0001628908-25-000109:0
5,546 shares@ US$8.9929.6% of flowClass A Common StockSEC:0001628908-25-000028:0
2,567 shares@ US$22.4433.0% of flowClass A Common StockSEC:0001628908-24-000082:0
7,491 shares0Class A Common StockSEC:0001628908-24-000040:0
2,188 shares@ US$30.4037.3% of flowClass A Common StockSEC:0001628908-23-000127:0
16,000 shares0Class A Common StockSEC:0001628908-23-000035:0
17,247 shares0Class A Common StockSEC:0001628908-22-000100:0
6,250 shares0Class A Common StockSEC:0001628908-22-000037:0
10 of 10 declarations
